Cybin Inc. (NEO:CYBN) (NYSE American:CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, today reported unaudited...
The article News You Might Have Missed: Nov 14th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
UNIFY founder Adil Kassam discusses how technology coupled with global group meditation can facilitate synchronized transformational experiences among...
The article Atai Reports Q3 Financials and Business Update was originally published on Microdose. atai Life Sciences has the biggest product portfolio...
Cybin Inc. (NEO:CYBN | (NYSE AMERICAN:CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, is pleased to announce...
LSD is back with a flurry of new applications to treat a broad array of conditions. The post LSD Finds New Life in Mental Health Circles...
Sensorium Therapeutics, which closed a $30 million Series A Tuesday, is embracing the complexity of neuropsychiatric diseases with nature-inspired psychoactive...
Big Pharma feeling pressure to join forces with psychedelics firms to develop mental health treatments The post Can Psychedelics Solve Big Pharma’s Mental...
Despite a challenging economy, psychedelics companies have accelerated development. The post Recession Predictions Not Slowing Psychedelics Industry appeared...
The article Decoding the Difference Between 5-MeO-DMT and N, N-DMT was originally published on Microdose. Some of the more perplexing and intriguing psychedelics...